Recent news coverage does not directly pertain to Stemtech Corp's business activities or financial performance.

• No recent business-specific news or developments related to Stemtech Corp were identified in the primary news sources [N1][N2][N3][N4][N5][N6][N7][N8].

Not applicable due to insufficient public information on business strategy, growth initiatives, or market positioning.

The company faces ongoing legal risks from litigation with a former CEO and financial risks from defaults on financing agreements. Liquidity ratios indicate potential financial stress with current liabilities far exceeding current assets, which may impact operational stability.

Due to limited public information on Stemtech Corp's business model, products, or competitive positioning, the company's moat or competitive advantages cannot be assessed with available data.

• Legal Proceedings: Ongoing litigation with a former CEO alleging unpaid compensation, with claims accrued on the balance sheet and unresolved as of the latest filings.
• Financial Default: Default under Merchant Cash Advance financing agreements with potential lender legal actions for recovery of outstanding balances.
• Liquidity Risk: Current ratio of 0.05 and cash ratio of 0.03 as of June 30, 2026, indicate low liquidity and potential challenges meeting short-term obligations.

• Stemtech Corp is a smaller reporting company as defined in Rule 12b-2 of the Exchange Act and is not required to provide certain detailed disclosures under Item 1A Risk Factors [S1][S2].
• The company has ongoing legal proceedings involving a lawsuit filed by a former CEO against its subsidiary, Stemtech Health Sciences Corp., alleging unpaid salary and vacation pay related to a period before current management took control in 2018. The claim amount is approximately $267,000. The company has filed a counterclaim and considers the claims without merit. The litigation remains ongoing as of the latest filings [S1].
• As of December 31, 2025, the company accrued $267,000 related to this legal matter, included in accounts payable and accrued liabilities [S1].
• The company was in default under certain Merchant Cash Advance financing agreements as of the latest filing date, with lenders potentially pursuing legal recovery of outstanding balances. These liabilities are fully reflected in the balance sheet as of December 31, 2025 [S1].
• Financial figures from the latest SEC filings include: revenue of $4,921,531 for the fiscal year ended December 31, 2023; net loss of $292,358 for the quarter ended June 30, 2026; basic and diluted EPS of $0 for the same quarter [S2].
• Liquidity snapshot as of June 30, 2026, shows cash and equivalents of $343,291, current assets of $571,233, current liabilities of $11,112,964, resulting in a current ratio of 0.05 and a cash ratio of 0.03, indicating low liquidity [S2].
• The company’s filings explicitly state that financial figures are provided for informational purposes only and do not constitute financial advice [S2].